Provided By PR Newswire
Last update: Sep 18, 2025
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNYSE:AGL (10/1/2025, 10:12:57 AM)
1.025
-0.01 (-0.49%)
Find more stocks in the Stock Screener